Symbol: |
MARK2
|
Description: |
MAP/microtubule affinity-regulating kinase 2 [Source:HGNC Symbol;Acc:3332]
|
Location: |
Chr11:63606400-63678491[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:431
Gene |
Compound |
Gen_sig |
Exp_pattern |
MARK2 |
NSC 376354 |
0.03 |
Down |
MARK2 |
NSC 382006 |
0.034 |
Down |
MARK2 |
NSC 405361 |
0.001 |
Down |
MARK2 |
Myricitin |
0.013 |
Down |
MARK2 |
Morpholine-N-dithiocarbamate |
0.001 |
Down |
MARK2 |
NSC 4271 |
0.013 |
Down |
MARK2 |
Neocuproin |
0.013 |
Down |
MARK2 |
NSC 600758 |
0.003 |
Down |
MARK2 |
RAPAMYCIN PRODRUG |
0.021 |
Up |
MARK2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.04 |
Up |
MARK2 |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
0.038 |
Down |
MARK2 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.001 |
Down |
MARK2 |
3-Deazaneplanocin, hydrochloride |
0.006 |
Down |
MARK2 |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.045 |
Up |
MARK2 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.012 |
Up |
Expression pattern: Sensitivity / Resistance
Total:29 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:23
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:89
Total:6 Current:1
[First] [Prev]  Next Last 
|